May 2003 :: Vol 33 No 5
Clinical and prevention
Achyuthan, K. E., Pence, L. M., Mantell, D. R., Nangeroni, P. E., Mauchan, D. M., Aitken, W. M., Appleman, J. R., and Shimasaki, C. D. (2003) Engineering a chemical implementation device and an imaging device for detecting chemiluminescence with a polaroid (TM) high-speed detector film: application to influenza diagnostics with the zstatflu (R)-ii test. Luminescence. vol. 18(2), 79-89
Anonymous (2003) CDC: Annual flu deaths higher than previously estimated. FDA Consumer. vol. 37(2), 8
Anonymous (2003) Recommended composition of influenza virus vaccines for use in the 2003-2004 influenza Season. Weekly Epidemiological Record. vol. 78(9), 58-62
Anonymous (2003) There are two sides to biodefence. Nature. vol. 422(6932), 545
Baltimore, R. S. and Jenson, H. B. (2003) New recommendations for influenza vaccination for children and pregnant women. Current Opinion in Pediatrics. vol. 15(1), 74-6
Bellei, N., Benfica, D., Perosa, A. H., Carlucci, R., Barros, M., and Granato, C. (2003) Evaluation of a rapid test (QuickVue) compared with the shell vial assay for detection of influenza virus clearance after antiviral treatment. Journal of Virological Methods. vol. 109(1), 85-88
Calabrese, F., Basso, C., Valente, M., and Thiene, G. (2003) Coronary thrombosis and sudden death after an enteroviral infection. Apmis. vol. 111(2), 315-318
Choudhri, Y. and Walop, W. (2002) Influenza vaccine-associated adverse events: results of passive surveillance, Canada 2001-2002. Canada Communicable Disease Report. vol. 28(23), 189-96
DeStefano, F., Verstraeten, T., Jackson, L. A., Okoro, C. A., Benson, P., Black, S. B., Shinefield, H. R., Mullooly, J. P., Likosky, W., Chen, R. T., and Vaccine Safety Datalink Research Group, N. Immunization= Program, Centers for Disease Control and Prevention (2003) Vaccinations and risk of central nervous system demyelinating diseases in adults. Archives of Neurology. vol. 60(4), 504-9
Farmer, J., Iversen, L., Peterkin, G., Strachan, P., Kelman, H., Proctor, K., and Emslie, M. (2001) Acceptability and uptake of a community-based flu immunisation programme. Health Bulletin. vol. 59(2), 127-35
Ferguson, N. M., Mallett, S., Jackson, H., Roberts, N., and Ward, P. (2003) A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals. Journal of Antimicrobial Chemotherapy. vol. 51(4), 977-990
Gerdil, C. (2003) The annual production cycle for influenza vaccine. Vaccine. vol. 21(16), 1776-1779
Hak, E., Hoes, A. W., Grobbee, D. E., Lammers, J. W. J., Van Essen, G. A., Van Loon, A. M., and Verheij, T. J. M. (2003) Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. American Journal of Epidemiology. vol. 157(8), 692-700
Harper, S., Klimov, A., Uyeki, T., and Fukuda, K. (2002) Influenza. [Review] [58 refs]. Clinics in Laboratory Medicine. vol. 22(4), 863-82
Hirsch, R. L. (2003) Vaccination rates: supply, demand, and tracking.[comment]. Archives of Internal Medicine. vol. 163(7), 849; author reply 849-50
Irvin, C. B., Nouhan, P. P., and Rice, K. (2003) Syndromic analysis of computerized emergency department patients' chief complaints: an opportunity for bioterrorism and influenza surveillance. Annals of Emergency Medicine. vol. 41(4), 447-52
Irwin, D. E., Weatherby, L. B., Huang, W. Y., Rosenberg, D. M., Cook, S. F., and Walker, A. M. (2001) Impact of patient characteristics on the risk of influenza/ILI-related complications. BMC Health Services Research. vol. 1(1), 8
Jonkers, R. E. and Boersma, W. G. (2003) [Pneumococcal vaccination in adults].[comment]. [Review] [50 refs] [Dutch]. Nederlands Tijdschrift voor Geneeskunde. vol. 147(10), 437-41
Kemble, G. and Greenberg, H. (2003) Novel generations of influenza vaccines. Vaccine. vol. 21(16), 1789-1795
Lange, W. and Vogel, G. E. (2003) [Oral neuraminidase inhibitor and an early warning system. New weapons against influenza]. [German]. MMW Fortschritte der Medizin. vol. 145(3-4), 36-7
Lange, W. and Vogel, G. E. (2003) [Rapid diagnosis at the bedside. True influenza or influenza-like infection?]. [German]. MMW Fortschritte der Medizin. vol. 145(3-4), 34-5
Mabrouk, T. and Ellis, R. W. (2002) Influenza vaccine technologies and the use of the cell-culture process (cell-culture influenza vaccine). Developments in Biologicals. vol. 110, 125-134
Machado, C. M., Boas, L. S. V., Mendes, A. V. A., Santos, M. F. M., Da Rocha, I. F., Sturaro, D., Dulley, F. L., and Pannuti, C. S. (2003) Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplantation. vol. 31(8), 695-700
Madeley, D. (2003) Prescription of neuraminidase inhibitors for influenza.[comment]. Journal of the Royal Society of Medicine. vol. 96(4), 207-8
McCullers, J. A. and Bartmess, K. C. (2003) Lethal synergism between influenza virus and streptococcus pneumoniae - reply. Journal of Infectious Diseases. vol. 187(10), 1674-1675
Meyers, D. G. (2003) Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination. [Review] [50 refs]. Current Atherosclerosis Reports. vol. 5(2), 146-9
Monto, A. S. (2003) The role of antivirals in the control of influenza. Vaccine. vol. 21(16), 1796-1800
Muller, H. E. (2003) Lethal synergism between influenza virus and streptococcus pneumoniae. Journal of Infectious Diseases. vol. 187(10), 1674
Nguyen-Van-Tam, J. S. and Hampson, A. W. (2003) The Epidemiology and clinical impact of pandemic influenza. Vaccine. vol. 21(16), 1762-1768
Nichol, K. L. (2003) The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine. vol. 21(16), 1769-1775
Noyola, D. E. (2003) Neuraminidase inhibitors in pediatric patients: potential place in influenza therapy. [Review] [50 refs]. Paediatric Drugs. vol. 5(2), 125-31
Ohkusa, Y. (2003) An analysis of the demand for influenza vaccination among the elderly in Japan. [Japanese]. Nippon Koshu Eisei Zasshi - Japanese Journal of Public Health. vol. 50(1), 27-38
Opp, M. R. and Toth, L. A. (2003) Neural-immune interactions in the regulation of sleep. Frontiers in Bioscience. vol. 8, D768-D779
Ortiz de Lejarazu, R. and Eiros, J. M. (2003) [Heading for systematic flu vaccination?]. [Spanish]. Medicina Clinica. vol. 120(9), 340-1
Osterhaus, A. D. M. E. (2003) Influenza vaccine. Vaccine. vol. 21(16), 1743
Scheifele, D., Duval, B., De Serres, G., and Skowronski, D. M. (2003) Unique roles of a data and safety monitoring board in vaccine safety trials with compressed timelines and urgent implications. Controlled Clinical Trials. vol. 24(1), 99-104
Selkova, E. P., Uzhaikin, V. F., Shumilov, V. I., Shuster, A. M., and Litus, V. I. (2002) [Organizational-methodological approaches to improvement of prevention and treatment of influenza and other acute respiratory viral infections ]. [Russian]. Russian Journal of Immunology. vol. 7(3), 301-6
Sheldon, T. (2003) Vet dies from pneumonia in avian flu case. BMJ. vol. 326(7396), 952
Shortridge, K. F. (2003) SARS exposed, pandemic influenza lurks. Lancet. vol. 361(9369), 1649
Smith, D. J. (2003) Applications of bioinformatics and computational biology to influenza surveillance and vaccine strain selection. Vaccine. vol. 21(16), 1758-1761
Storch, G. A. (2003) Rapid diagnostic tests for influenza. [Review] [34 refs]. Current Opinion in Pediatrics. vol. 15(1), 77-84
Van Essen, G. A., Palache, A. M., Forleo, E., and Fedson, D. S. (2003) Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine. vol. 21(16), 1780-1785
Van Kolfschooten, F. (2003) Dutch veterinarian becomes first victim of avian influenza. Lancet. vol. 361(9367), 1444
Wood, J. M. and Levandowski, R. A. (2003) The influenza vaccine licensing process. Vaccine. vol. 21(16), 1786-1788
Yao, D., Kuwajima, M., and Kido, H. (2003) Pathologic mechanisms of influenza encephalitis with an abnormal expression of inflammatory cytokines and accumulation of mini-plasmin. [Review] [35 refs]. Journal of Medical Investigation. vol. 50(1-2), 1-8
Epidemiology
Abbott, A. (2003) Human fatality adds fresh impetus to fight against bird flu. Nature. vol. 423(6935), 5
Aguilera, J. F., Paget, W. J., and van der Velden, J. (2002) Development of a protocol to evaluate the quality of clinical influenza data collected by sentinel practitioners in Europe. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(11), 158-60
Ammon, C. E. (2002) Spanish flu epidemic in 1918 in Geneva, Switzerland. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(12), 190-2
Anonymous (2003) Influenza fact sheet. Weekly Epidemiological Record. vol. 78(11), 77-80
Anonymous (2003) Influenza outbreak in the district of Bosobolo, Democratic Republic of the Congo, November-December 2002. Weekly Epidemiological Record. vol. 78(13), 94-6
Anonymous (2002) Influenza under close surveillance.[comment]. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(12), 171
Anonymous (2002) It's time to get ready for the coming flu season! Michigan Medicine. vol. 101(5), 38
Cox, N. J., Tamblyn, S. E., and Tam, T. (2003) Influenza pandemic planning. Vaccine. vol. 21(16), 1801-1803
Ellis, J. S., Alvarez-Aguero, A., Gregory, V., Lin, Y. P., Hay, A., and Zambon, M. C. (2003) Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season. Emerging Infectious Diseases. vol. 9(3), 304-10
Enserink, M. (2003) Infectious diseases - avian flu outbreak sets off alarm bells. Science. vol. 300(5620), 718
Fleming, D. M., Van Der Velden, J., and Paget, W. J. (2003) The evolution of influenza surveillance in Europe and prospects for the next 10 years. Vaccine. vol. 21(16), 1749-1753
Fock, R., Bergmann, H., Bussmann, H., Fell, G., Finke, E. J., Koch, U., Niedrig, M., Peters, M., Riedmann, K., Scholz, D., and Wirtz, A. (2002) Influenza pandemic: preparedness planning in Germany. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(1), 1-5
Fouchier, R. A. M., Osterhaus, A. D. M. E., and Brown, I. H. (2003) Animal influenza virus surveillance. Vaccine. vol. 21(16), 1754-1757
Gregory, V., Bennett, M., Thomas, Y., Kaiser, L., Wunderli, W., Matter, H., Hay, A., and Lin, Y. P. (2003) Human infection by a swine influenza A (H1N1) virus in Switzerland. Archives of Virology. vol. 148(4), 793-802
Hampson, A. W. (2002) Pandemic influenza: history, extent of the problem and approaches to control. Developments in Biologicals. vol. 110, 115-123
Karcher, F. and Buchow, H. (2002) Influenza pandemic preparedness and response planning at community level. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(11), 166-8
Lange, W. (2003) [Influenza--the last big epidemic. What makes it so dangerous?]. [German]. MMW Fortschritte der Medizin. vol. 145(3-4), 32-4
Leitmeyer, K., Buchholz, U., Kramer, M., and Schweiger, B. (2002) Enhancing the predictive value of throat swabs in virological influenza surveillance. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(12), 180-3
Li, S., Perdue, M. L., and Patzer, E. (2002) Seed viruses containing novel avian HA and NA antigens for prevention against potential influenza pandemic. Developments in Biologicals. vol. 110, 135-141
Luthi, J. C., Mean, F., Ammon, C., and Burnand, B. (2002) Evaluation of a population-based prevention program against influenza among Swiss elderly people. Swiss Medical Weekly. vol. 132(41-42), 592-7
Macey, J. F., Tam, T. W., Li, Y., Winchester, B., and Zabchuk, P. (2003) Influenza in Canada: 2001-2002 Season. Canada Communicable Disease Report. vol. 29(6), 45-59
Mooney, J. D., Holmes, E., and Christie, P. (2002) Real-time modelling of influenza outbreaks--a linear regression analysis. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(12), 184-7
Paget, W. J., Meerhoff, T. J., Goddard, N. L., and EISS (2002) Mild to moderate influenza activity in Europe and the detection of novel A(H1N2) and B viruses during the winter of 2001-02. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(11), 147-57
Parker, D., Alcorn, M., and Johnston, A. (2003) Outbreak of highly pathogenic avian influenza in The Netherlands. Veterinary Record. vol. 152(11), 338
Regan, C. M., Sopwith, W., Syed, Q., Painter, M., Mutton, K., and Paver, K. (2002) Surveillance of influenza in the North-West Region of England 2001-02. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(12), 174-80
Shortridge, K. F., Peiris, J. S. M., and Guan, Y. (2003) The next influenza pandemic: lessons from Hong Kong. Journal of Applied Microbiology. vol. 94, 70S-79S
Stohr, K. (2003) The global agenda on influenza surveillance and control. Vaccine. vol. 21(16), 1744-1748
Uyeki, T. M., Zane, S. B., Bodnar, U. R., Fielding, K. L., Buxton, J. A., Miller, J. M., Beller, M., Butler, J. C., Fukuda, K., Maloney, S. A., Cetron, M. S., and Alaska/Yukon Territory Respiratory Outbreak Investigation Team (2003) Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory. Clinical Infectious Diseases. vol. 36(9), 1095-102
WHO-GOARN investigation team (2002) Outbreak of influenza, Madagascar, July-August 2002.[comment]. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 7(12), 172-4
Immunology
Banzhoff, A., Nacci, P., and Podda, A. (2003) A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis. Gerontology. vol. 49(3), 177-184
Bright, R. A., Ross, T. M., Subbarao, K., Robinson, H. L., and Katz, J. M. (2003) Impact of glycosylation on the immunogenicity of a DNA-based influenza H5HA vaccine. Virology. vol. 308(2), 270-278
Brydak, L. B., Machala, M., Mysliwska, J., Mysliwski, A., and Trzonkowski, P. (2003) Immune response to influenza vaccination in an elderly population. Journal of Clinical Immunology. vol. 23(3), 214-222
de Castro, I. P., Diaz, R., Malumbres, M., Hernandez, M. I., Jagirdar, J., Jimenez, M., Ahn, D., and Pellicer, A. (2003) Mice deficient for N-ras: impaired antiviral immune response and T-cell function. Cancer Research. vol. 63(7), 1615-22
Guebre-Xabier, M., Hammond, S. A., Epperson, D. E., Yu, J. M., Ellingsworth, L., and Glenn, G. M. (2003) Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. Journal of Virology. vol. 77(9), 5218-5225
Hayney, M. S. and Buck, J. M. (2002) Effect of age and degree of immune activation on cytochrome P450 3A4 activity after influenza immunization. Pharmacotherapy. vol. 22(10), 1235-8
Liu, B. X., Mori, I., Hossain, M. J., Dong, L., Chen, Z. M., and Kimura, Y. (2003) Local immune responses to influenza virus infection in mice with a targeted disruption of perforin gene. Microbial Pathogenesis. vol. 34(4), 161-167
Manoury, B., Mazzeo, D., Li, D. N., Billson, J., Loak, K., Benaroch, P., and Watts, C. (2003) Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. Immunity. vol. 18(4), 489-98
Turner, S. J., Diaz, G., Cross, R., and Doherty, P. C. (2003) Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response. Immunity. vol. 18(4), 549-559
Wattrang, E., Jessett, D. M., Yates, P., Fuxler, L., and Hannant, D. (2003) Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses. Viral Immunology. vol. 16(1), 57-67
Wohlleben, G., Muller, J., Tatsch, U., Hambrecht, C., Herz, U., Renz, H., Schmitt, E., Moll, H., and Erb, K. J. (2003) Influenza A virus infection inhibits the efficient recruitment of TH2 cells into the airways and the development of airway eosinophilia. Journal of Immunology. vol. 170(9), 4601-4611
Structure, function and genetics
Epand, R. F. and Epand, R. M. (2003) Irreversible unfolding of the neutral pH form of influenza hemagglutinin demonstrates that it is not in a metastable state. Biochemistry. vol. 42(17), 5052-5057
Gastaminza, P., Perales, B., Falcon, A. M., and Ortin, J. (2003) Mutations in the N-terminal region of influenza virus PB2 protein affect virus RNA replication but not transcription. Journal of Virology. vol. 77(9), 5098-5108
Hanessian, S., Bayrakdarian, M., and Luo, X. H. (2003) Total synthesis of a-315675: A potent inhibitor of influenza neuraminidase. (Vol 124, pg 4716, 2002). Journal of the American Chemical Society. vol. 125(16), 4958
Rajbhandari, M., Wegner, U., Schopke, T., Lindequist, U., and Mentel, R. (2003) Inhibitory effect of bergenia ligulata on influenza virus A. Pharmazie. vol. 58(4), 268-271
Sieczkarski, S. B. and Whittaker, G. R. (2003) Differential requirements of RAB5 and RAB7 for endocytosis of influenza and other enveloped viruses. Traffic. vol. 4(5), 333-343
Totani, K., Kubota, T., Kuroda, T., Murata, T., Hidari, K. I. P. J., Suzuki, T., Suzuki, Y., Kobayashi, K., Ashida, H., Yamamoto, K., and Usui, T. (2003) Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(l-glutamic acid) backbone for inhibition of infection by influenza viruses. Glycobiology. vol. 13(5), 315-326
Toth, L. A. and Verhulst, S. J. (2003) Strain differences in sleep patterns of healthy and influenza-infected inbred mice. Behavior Genetics. vol. 33(3), 325-336